Camden National Corporation’s Medtronic MDT Stock Holding History

Camden National Corporation’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$7.05M	Buy	+59,716	New	+$7M	1.41%	31

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Camden National Corporation's MDT Position: Q1 2021 in Review

Camden National Corporation opened a new position in Medtronic (MDT) in Q1 2021: 59,716 shares worth $7.05M. The stake represents 1.41% of the portfolio and ranks #31 among its holdings.

1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

Camden National Corporation held 59,716 shares of Medtronic worth $7.05M as of Q1 2021.
Medtronic was a new Camden National Corporation position in Q1 2021.
Medtronic made up 1.41% of Camden National Corporation's portfolio in Q1 2021, its #31 holding.
1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.